Original Article
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries
Desenlaces reportados por los pacientes diagnosticados con AR tratados con tofacitinib o FARME biológico bajo condiciones reales en dos países de Latinoamérica
J.M. Reyesa,
, M.V. Gutierrezb, H. Madariagac, W. Oterod, R. Guzmane, J. Izquierdof, M. Abellog, P. Velezh, D. Castillof, D. Ponce de Leoni, T. Lukicj, L. Amadora
Corresponding author
a Pfizer, Bogota, Colombia
b Pfizer, Santiago, Chile
c Centro Especializado de enfermedades neoplásicas (CEEN), Arequipa, Peru
d Centro Servimed, Bucaramanga, Colombia
e Instituto de Enfermedades Autoinmunes Renato Guzmán (IDEARG), Bogota, Colombia
f Clínica del Occidente, Cali, Colombia
g Centro Integral de Reumatología Circaribe, Barranquilla, Colombia
h Centro de Investigación en Reumatología y Especialidades Médicas (CIREEM), Bogota, Colombia
i Pfizer, Lima, Peru
j Pfizer Inc, New York, USA
Ver másRead
2824
Timeswas read the article
588
Total PDF
2236
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 48 | 15 | 63 |
| 2024 November | 66 | 61 | 127 |
| 2024 October | 87 | 57 | 144 |
| 2024 September | 459 | 48 | 507 |
| 2024 August | 388 | 64 | 452 |
| 2024 July | 335 | 60 | 395 |
| 2024 June | 286 | 90 | 376 |
| 2024 May | 255 | 46 | 301 |
| 2024 April | 141 | 28 | 169 |
| 2024 March | 53 | 29 | 82 |
| 2024 February | 40 | 31 | 71 |
| 2024 January | 46 | 26 | 72 |
| 2023 December | 29 | 30 | 59 |
| 2023 November | 3 | 3 | 6 |
Show all
